Articles tagged with Psychopharmacology
The British Association for Psychopharmacology has released new guidelines to guide psychiatrists and physicians in treating sleep disorders. These guidelines recommend cognitive behavioral therapy as an effective treatment option for insomnia, which can be improved with specialist targeted therapy. The guidelines also address specific...
A study published in Journal of Psychopharmacology found that MDMA, a pharmaceutical version of Ecstasy, can enhance the effectiveness of exposure therapy for PTSD. By increasing oxytocin levels and reducing fear responses, ecstasy may help patients overcome traumatic memories and reduce stress.
Researchers at Johns Hopkins Medicine have found that the spiritual effects of psilocybin, a hallucinogen, can last more than a year. Most volunteer subjects reported the experience as one of the most personally meaningful and spiritually significant events of their lives.
New British Association of Pharmacology guidelines suggest that antidepressants are effective in treating depression, especially severe cases. In contrast, evidence for cognitive behavioural therapy (CBT) is limited, particularly for mild and moderate depression.
Experts warn that psychotherapies like CBT can have serious adverse effects, including worsening of conditions, psychological dependency, and exploitation. They call for rigorous regulation and monitoring to ensure patient safety and effectiveness.
Research explores alternative models for reducing alcohol consumption, including tax incentives and low-alcohol drinks. Pharmacological investigation into safe substitutes like partial agonists could hold the key to eradicating alcohol misuse problems.
A recent study found that daily smokers experience impaired time estimation when abstaining from cigarettes for 24 hours. This impairment may contribute to feelings of stress and decreased focus, highlighting the need for further research on nicotine's effects on attention processes.